These medications exert (in)direct hepatic actions by reducing steatosis, attenuating inflammation, and potentially reversing fibrosis, while simultaneously addressing systemic metabolic abnormalities including excessive obesity, insulin resistance, and cardiovascular risk
As Lauren put it: Many of my clients feel guilty about considering GLP-1s, as if theyve failed. But in reality, theyve tried everything, and this is simply another tool to support them. At Black Iron, we support every individuals unique health journey including those who choose GLP-1s with a well-rounded plan for long-term success
CareBareRX's published materials discuss GLP-1 medications and include semaglutide-related safety and compounding disclosures
Ach, an excitatory neurotransmitter in the ENS, promotes smooth muscle motility and inhibits NO